Chimeric Therapeutics Limited - Assembling a World-Class Team, Partners and Assets
Chimeric Therapeutics Limited Assembling a world-class team, partners and assets Chimeric Therapeutics Limited (ASX:CHM) is a...
Chimeric Therapeutics Ltd - Entitlement Offer to Raise up to $18.1M
Chimeric Therapeutics Ltd Entitlement offer to raise up to $18.1M Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company...
Chimeric Therapeutics Ltd: Hitting Milestones and Pipeline Flowing
Chimeric Therapeutics Ltd Hitting milestones and pipeline flowing Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company...
Chimeric Therapeutics Ltd: Adding to the Pipeline with a Clinical Platform Technology
Chimeric Therapeutics Ltd Adding to the pipeline with a clinical platform technology Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell...
Chimeric Therapeutics - Acquiring an exciting new NK cell technology
Chimeric has announced that it has entered into an exclusive option agreement to license the clinically validated, off the shelf, robust, enhanced...
No more insights